Tranexamic Acid
In plain terms
A brightening active for melasma and dark spots that is gentle and well tolerated, even on sensitive skin. The clotting concern attached to its name comes from the oral and IV drug used to stop bleeding, not from the cream, which barely gets past the skin surface.
What the evidence shows
Tranexamic acid started as a medicine that slows the breakdown of blood clots, and at oral or intravenous drug doses it can raise the risk of clots, which is why systemic use is supervised and avoided in pregnancy and in people prone to thrombosis. Applied to skin as a cosmetic, it is a different story. Topical tranexamic acid is barely absorbed into the bloodstream, so the clotting concern does not carry over, and reviews put its overall thrombotic risk from skin use as low. What it does well on skin is interrupt the signal between skin cells and pigment cells, which fades melasma and dark spots; clinical trials at 2 to 5% find it works about as well as hydroquinone with fewer irritant reactions, and it is gentle enough for redness-prone skin. It is recognized for cosmetic use in the EU ingredient database, and allergy to it is rare. The honest limit is that it is a newer cosmetic active with a shorter track record than the old standbys, but so far the topical safety record is good.
On the label
Listed as tranexamic acid. The blood-clot warnings you may find apply to the swallowed or injected drug, not the cosmetic cream. As a brightener it pairs well with vitamin C and sunscreen for pigment concerns.